SIC
MXCT icon

SJS Investment Consulting’s MaxCyte MXCT Stock Holding History

SJS Investment Consulting’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155 Buy
126
+94
+294% +$94 ﹤0.01% 2522
2026
Q1 		$23 Buy
+32
New +$30 ﹤0.01% 2355

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KL
KWMG LLC Overland Park, Kansas $1.38B AUM 33.35% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SJS Investment Consulting's MXCT Position: Q2 2026 in Review

SJS Investment Consulting increased its MaxCyte (MXCT) stake by 294% in Q2 2026, buying an estimated $94 and bringing the position to 126 shares worth $155. The position accounts for ﹤0.01% of the portfolio, ranked #2522.

SJS Investment Consulting first reported a position in MXCT in Q1 2026 and has held it in 2 quarters since. 18 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • SJS Investment Consulting held 126 shares of MaxCyte worth $155 as of Q2 2026.
  • SJS Investment Consulting bought 94 MaxCyte shares in Q2 2026, an estimated $94.
  • MaxCyte made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2522 holding.
  • SJS Investment Consulting first reported a position in MaxCyte in Q1 2026 and has held it in 2 quarters since.
  • 18 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.